Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (2947)	5/24/1999 7:56:00 PM
From: Bob Swift	Read Replies (2) \| Respond to of 10280

Lots of talk on its way up, complete silence on its way down. If the management is so screwy in dealing with investors, how competent is it in selling the drugs ? Last time SEPR lost 2/3 of its value (from something like 21 to less than 7 in a few months), it took almost a year for the price to recover. At the current rate, we will see a decline of the peak market cap to 1/3 of its value in a couple of days if not sooner. How long before it can regain its strength in this 40% overvalued market(heard on CNBC), which starts to crack at this moment, is anyone's guess. Tell me if I am wrong, but all day today, any remote attempt to rebound was met with "I'm getting out" sellings. At this point, it may be a little too late to sell, or is it ? Of course, it is always the worst at the bottom. May be if we pray hard enough, some licensing agreement may come forth.